New Medical Acrylics Debut at MD&M West
Röhm adds two new products to its Cyrolite portfolio suited for medical applications.
February 8, 2023
Röhm is launching two new medical products in its Cyrolite portfolio of materials at the co-located Plastec West and Medical Design & Manufacturing (MD&M) West event in Anaheim this week.
Cyrolite G-20 CP is a polymethyl methacrylate (PMMA)–based copolymer for injection molding and extrusion of UV-light protective medical applications. Cyrolite G-20 CP ensures integrity of photosensitive substances such as oncology drugs, antibiotics, and antifungal agents that require UV-light protection.
The material features:
Low UV-light transmission <1.0% 260 - 480 nm.
Excellent transmittance between 500 and 780 nm.
With outstanding processability and unique bonding properties, Cyrolite G-20 CP has five times the impact resistance of unmodified acrylics and high resistance to body fluids and other chemicals, according to Röhm.
Cyrolite MD zk6 acrylic polymer is an amorphous, impact-modified thermoplastic injection molding and extrusion compound based on PMMA for the medical device and diagnostics industry. High impact resistance and ductility/toughness make Cyrolite MD zk6 suited for applications like dialysis cassettes, test packs, filter housings, microfluidics, luers, tube connectors, IV catheter hubs, and Y sites.
The compound has three times the impact resistance of other medical-grade acrylics and features high light transmission with little haze, said Röhm.
The company is showcasing these products in booth 1389 at MD&M West/Plastec West in Anaheim, CA, from Feb. 7 to 9, 2023.
You May Also Like